nach oben

Current HIV/AIDS Reports

Erschienen in:

27.10.2021 | The Science of Prevention (R Heffron and K Ngure, Section Editors)

Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine

verfasst von: E. Rousseau, R. F. Julies, N. Madubela, S. Kassim

Erschienen in: Current HIV/AIDS Reports | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

A gap exists between PrEP interest and PrEP uptake in key populations (KP) for HIV prevention that may be ascribed to PrEP delivery services not being acceptable. This review summarizes novel platforms for HIV prevention outside of the traditional health facilities environment.

Recent Findings

Mobile health clinics provide highly acceptable integrated, KP-focused services at convenient locations with the potential of high PrEP uptake. Telemedicine and health apps decongest health systems and allow for personal agency and informed decision-making on personal health. Pharmacy-led PrEP delivery provides de-medicalized, confidential PrEP services at extended hours in community locations, from trusted medical professionals. Peer-supported delivery encourages continued PrEP use.

Summary

Community-based, differentiated and de-medicalized PrEP delivery can address uptake and continued use barriers in key populations. Future research should assess scalability, cost-effectiveness and sustainability of these PrEP delivery platforms, as well as focus on ways to simplify PrEP provision.

• Celum CL, Delany-Moretlwe S, Baeten JM, van der Straten A, Hosek S, Bukusi EA, et al. HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery. J Int AIDS Soc. 2019;22:e25298. Important article on the role of PrEP delivery design and support on PrEP uptake and use in AGYW.

Ahmed N, Pike C, Bekker L-G. Scaling up pre-exposure prophylaxis in sub-Saharan Africa. Curr Opin Infect Dis. 2019;32(1):24–30.PubMed

Rousseau E, Katz AW, O’Rourke S, Bekker L-G, Delany-Moretlwe S, Bukusi E, et al. Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya. PloS one. 2021;16(10):e0258542.

Larsen A, Wilson KS, Kinuthia J, John-Stewart G, Richardson B, Pintye J et al. Protocol: standardised patient encounters to improve quality of counselling for pre-exposure prophylaxis (PrEP) in adolescent girls and young women (AGYW) in Kenya: study protocol of a cluster randomised controlled trial. BMJ Open. 2020;10(6).

Lau JY, Hung CT, Lee SS. A review of HIV pre-exposure prophylaxis (PrEP) programmes by delivery models in the Asia-Pacific through the healthcare accessibility framework. J Int AIDS Soc. 2020;23(7):e25531.PubMedPubMedCentral

Levesque J-F, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. Int J Equity Health. 2013;12(1):1–9.

Hillis A, Germain J, Hope V, McVeigh J, Van Hout MC. Pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM): a scoping review on PrEP service delivery and programming. AIDS Behav. 2020;24(11):3056–70.PubMedPubMedCentral

Calabrese SK, Galvao RW, Dovidio JF, Willie TC, Safon CB, Kaplan C, et al. Contraception as a potential gateway to pre-exposure prophylaxis: US women’s pre-exposure prophylaxis modality preferences align with their birth control practices. AIDS Patient Care STDs. 2020;34(3):132–46.PubMedPubMedCentral

Velloza J, Kapogiannis B, Bekker L-G, Celum C, Hosek S, Delany-Moretlwe S, et al. Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services? AIDS (London, England). 2021;35(3):463.

10.

WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 5: Monitoring and evaluation. (2018).

11.

• Beckham SW, Crossnohere NL, Gross M, Bridges JF. Eliciting preferences for HIV prevention technologies: a systematic review. The Patient-Patient-Centered Outcomes Research. 2020:1-24. Systematic review of DCE's, conjoint analysis, etc. indicating user preference for HIV prevention methods as well as delivery (method, location, provider type).

12.

Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):21484.PubMedPubMedCentral

13.

Duncombe C, Rosenblum S, Hellmann N, Holmes C, Wilkinson L, Biot M, et al. Reframing HIV care: putting people at the centre of antiretroviral delivery. Trop Med Int Health. 2015;20(4):430–47.PubMedPubMedCentral

14.

Yu SWY, Hill C, Ricks ML, Bennet J, Oriol NE. The scope and impact of mobile health clinics in the United States: a literature review. Int J Equity Health. 2017;16(1):178. https://doi.org/10.1186/s12939-017-0671-2.CrossRefPubMedPubMedCentral

15.

Blackstock OJ, Platt J, Golub SA, Anakaraonye AR, Norton BL, Walters SM et al. A pilot study to evaluate a novel pre-exposure prophylaxis peer outreach and navigation intervention for women at high risk for HIV infection. AIDS Behav. 2020:1-12.

16.

Neke NM, Gadau G, Wasem J. Policy makers’ perspective on the provision of maternal health services via mobile health clinics in Tanzania—findings from key informant interviews. PloS One. 2018;13(9):e0203588.PubMedPubMedCentral

17.

Bassett IV, Govindasamy D, Erlwanger AS, Hyle EP, Kranzer K, van Schaik N, et al. Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness. PloS One. 2014;9(1):e85197.PubMedPubMedCentral

18.

Smith P, Tolla T, Marcus R, Bekker L-G. Mobile sexual health services for adolescents: investigating the acceptability of youth-directed mobile clinic services in Cape Town South Africa. BMC Health Serv Res. 2019;19(1):1–7.

19.

Sharma M, Chris A, Chan A, Knox DC, Wilton J, McEwen O, et al. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol. BMC Health Serv Res. 2018;18(1):1–10.

20.

Bassett IV, Regan S, Luthuli P, Mbonambi H, Bearnot B, Pendleton A, et al. Linkage to care following community-based mobile HIV testing compared with clinic-based testing in U mlazi T ownship, D urban South Africa. HIV Med. 2014;15(6):367–72.PubMed

21.

Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker L-G. PrEP as a lifestyle and investment for adolescent girls and young women in sub-Saharan Africa. J Int Assoc Providers AIDS Care (JIAPAC). 2019;18:2325958219831011.

22.

Rousseau E, Baeten JM, Morton JF, Johnson R, Celum CL, Bekker L-G. Association between contraceptive use and PrEP uptake and continuation in adolescent girls and young women in Cape Town, South Africa. Mexico City Mexico: International AIDS Society Conference; 2019.

23.

Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, et al. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020;23(6):e25528.PubMedPubMedCentral

24.

Rousseau E, Bekker L-G, Julies RF, Celum C, Morton J, Johnson R, et al. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa. BMC Health Serv Res. 2021;21(1):1–10.

25.

Celum C, Bukusi EB, Bekker LG, Delany-Moretlwe S, Kidoguchi L, Omollo V, et al. PrEP initiation, persistence, and HIV seroconversion rates in African adolescent girls and young women (AGYW) from Kenya and South Africa: the POWER demonstration project. HIVR4P Virtual Conference. 2021. https://programme.hivr4p.org/Abstract/Abstract/889. Accessed 29 Jan 2021.

26.

Mulhausen J, Croucamp Y, Malone S, Shashikumar A, Noble-Campbell P, Gomez A, et al. Understanding HIV prevention in high-risk adolescent girls and young women in two South African provinces South African. Health Rev. 2019;2019(1):167–71.

27.

Ciranka S, van den Bos W. Social influence in adolescent decision-making: a formal framework. Front Psychol. 2019;10:1915.PubMedPubMedCentral

28.

O’Rourke S, Hartmann M, Myers L, Lawrence N, Gill K, Morton JF et al. The PrEP journey: Understanding how internal drivers and external circumstances impact the PrEP trajectory of adolescent girls and young women in Cape Town, South Africa. AIDS Behav. 2021:1-12.

29.

O'Malley G, Roche SD, Rousseau E, Travill D, Omollo V, Delany-Moretlwe S, et al. "Health care providers as agents of change: integrating PrEP with other sexual and reproductive health services for adolescent girls and young women". Front Reprod Health. 2021.https://doi.org/10.3389/frph.2021.668672

30.

Baron D, Scorgie F, Ramskin L, Khoza N, Schutzman J, Stangl A, et al. “You talk about problems until you feel free”: South African adolescent girls’ and young women’s narratives on the value of HIV prevention peer support clubs. BMC Public Health. 2020;20(1):1–13.

31.

Mebane S. Community-Based Pre-Exposure Prophylaxis Implementation in Rural KwaZulu-Natal: A Feasibility Study Doctoral dissertation, Harvard Medical School. 2020.

32.

Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18(6):e1003670.

33.

Pampati S, Andrzejewski J, Steiner RJ, Rasberry CN, Adkins SH, Lesesne CA, et al. “We deserve care and we deserve competent care”: qualitative perspectives on health care from transgender youth in the Southeast United States. J Pediatr Nurs. 2021;56:54–9.PubMed

34.

Shahmanesh M, Okesola N, Chimbindi N, Zuma T, Mdluli S, Mthiyane N et al. Thetha Nami: Participatory development of a peer-navigator intervention to deliver biosocial HIV prevention for adolescents and young men and women in rural South Africa. 2020.

35.

Pagkas-Bather J, Jaramillo J, Henry J, Grandberry V, Ramirez LF, Cervantes L, et al. What’s PrEP?: peer navigator acceptability among minority MSM in Washington. BMC Public Health. 2020;20(1):1–12.

36.

Dubov A, Altice FL, Fraenkel L. An information–motivation–behavioral skills model of PrEP uptake. AIDS Behav. 2018;22(11):3603–16.PubMed

37.

Rodrigues J. Easier and equitable access to PrEP: How DSD can help get us there. 2020. https://differentiatedservicedelivery.org/Resources/Resource-Library/Easier-and-equitable-access-to-PrEP#. Accessed 12 May 2021.

38.

• Phanuphak N, Sungsing T, Jantarapakde J, Pengnonyang S, Trachunthong D, Mingkwanrungruang P, et al. Princess PrEP program: the first key population-led model to deliver pre-exposure prophylaxis to key populations by key populations in Thailand. Sexual health. 2018;15(6):542–55. Description of key population-led PrEP delivery program to enhance key population engagement with services and initiation on PrEP.

39.

Khosropour CM, Backus KV, Means AR, Beauchamps L, Johnson K, Golden MR, et al. A pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP initiation. AIDS Patient Care STDs. 2020;34(1):1–6.PubMedPubMedCentral

40.

• Crawford ND, Myers S, Young H, Klepser D, Tung E. The role of pharmacies in the HIV prevention and care continuums: a systematic review. AIDS Behav. 2021:1-10. Systematic review on role of pharmacies in HIV prevention, including feasibility, acceptability and highlighting gaps in current practice and suggestions for future implementation.

41.

Crawford ND, Albarran T, Chamberlain A, Hopkins R, Josma D, Morris J et al. Willingness to discuss and screen for pre-exposure prophylaxis in pharmacies among men who have sex with men. J Pharm Pract. 2020:0897190020904590.

42.

Crawford ND, Josma D, Morris J, Hopkins R, Young HN. Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men. J Am Pharm Assoc. 2020;60(4):602–8.

43.

Koester KA, Saberi P, Fuller SM, Arnold EA, Steward WT. Attitudes about community pharmacy access to HIV prevention medications in California. J Am Pharm Assoc. 2020;60(6):e179–83.

44.

Tung E, Thomas A, Hansen R. One-step PrEP: A Pharmacist-run HIV Pre-exposure Prophylaxis (PrEP) Clinic in a Community Pharmacy Setting. Proceedings of the 2015 National HIV Prevention Conference; 2015.

45.

Darin KM, Klepser ME, Klepser DE, Klepser SA, Reeves A, Young M, et al. Pharmacist-provided rapid HIV testing in two community pharmacies. J Am Pharm Assoc. 2015;55(1):81–8.

46.

Amesty S, Crawford ND, Nandi V, Perez-Figueroa R, Rivera A, Sutton M, et al. Evaluation of pharmacy-based HIV testing in a high-risk New York City community. AIDS Patient Care STDs. 2015;29(8):437–44.PubMed

47.

Hopkins R, Josma D, Morris J, Klepser DG, Young HN, Crawford ND. Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: examining concordance between pharmacy technicians and pharmacists. J Am Pharm Assoc. 2021;61(1):115–20.

48.

Vanhamel J, Rotsaert A, Reyniers T, Nöstlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20(1):1–18.

49.

Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, et al. Young women’s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019;80(4):394.PubMedPubMedCentral

50.

Hosek S, Pettifor A. HIV prevention interventions for adolescents. Curr HIV/AIDS Rep. 2019;16(1):120–8.PubMedPubMedCentral

51.

Swenson I, Gates TG, Dentato MP, Kelly BL. Strengths-based behavioral telehealth with sexual and gender diverse clients at Center on Halsted. Soc Work Health Care. 2021;60(1):78–92.PubMed

52.

Touger R, Wood BR. A review of telehealth innovations for HIV pre-exposure prophylaxis (PrEP). Curr HIV/AIDS Rep. 2019;16(1):113–9.PubMed

53.

Hosek S, Celum C, Wilson CM, Kapogiannis B, Delany-Moretlwe S, Bekker LG. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa. J Int AIDS Soc. 2016;19:21107.PubMedPubMedCentral

54.

Wong KYK, Stafylis C, Klausner JD. Telemedicine: a solution to disparities in human immunodeficiency virus prevention and pre-exposure prophylaxis uptake, and a framework to scalability and equity. Mhealth. 2020;6.

55.

Li C, Xiong Y, Muessig KE, Huang H, Mu T, Tong X et al. A community-engaged mHealth intervention to increase uptake of HIV Pre-Exposure Prophylaxis (PrEP) among gay, bisexual and other men who have sex with men in China: study protocol for a pilot randomized controlled trial. medRxiv. 2020.

56.

Li DH, Brown CH, Gallo C, Morgan E, Sullivan PS, Young SD, et al. Design considerations for implementing eHealth behavioral interventions for HIV prevention in evolving sociotechnical landscapes. Curr HIV/AIDS Rep. 2019;16(4):335–48.PubMedPubMedCentral

57.

Dietrich JJ, Benadé GL, Mulaudzi M, Kagee A, Hornschuh S, Makhale LM, et al. “You are on the right track with the app:” Qualitative Analysis of mobile phone use and user feedback regarding mobile phone sexual risk assessments for HIV prevention research. Front Digit Health. 2021;3:21.

58.

Aliabadi N, Carballo-Dieguez A, Bakken S, Rojas M, Brown W III, Carry M, et al. Using the information-motivation-behavioral skills model to guide the development of an HIV prevention smartphone application for high-risk MSM. AIDS Educ Preven. 2015;27(6):522–37.

59.

Ybarra ML, Korchmaros JD, Prescott TL, Birungi R. A randomized controlled trial to increase HIV preventive information, motivation, and behavioral skills in Ugandan adolescents. Ann Behav Med. 2015;49(3):473–85.PubMed

60.

Songtaweesin WN, Kawichai S, Phanuphak N, Cressey TR, Wongharn P, Saisaengjan C, et al. Youth-friendly services and a mobile phone application to promote adherence to pre-exposure prophylaxis among adolescent men who have sex with men and transgender women at-risk for HIV in Thailand: a randomized control trial. J Int AIDS Soc. 2020;23:e25564.PubMedPubMedCentral

61.

Anand T, Nitpolprasert C, Trachunthong D, Kerr SJ, Janyam S, Linjongrat D, et al. A novel Online-to-Offline (O2O) model for pre-exposure prophylaxis and HIV testing scale up. J Int AIDS Soc. 2017;20(1):21326.PubMedPubMedCentral

62.

Stevens DR, Vrana CJ, Dlin RE, Korte JE. A global review of HIV self-testing: themes and implications. AIDS Behav. 2018;22(2):497–512.PubMedPubMedCentral

63.

Ortblad KF, Kearney JE, Mugwanya K, Irungu EM, Haberer JE, Barnabas RV, et al. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya. Trials. 2019;20(1):1–10.

64.

Wachinger J, Kibuuka Musoke D, Oldenburg CE, Bärnighausen T, Ortblad KF, McMahon SA. “But i gathered my courage”: HIV self-testing as a pathway of empowerment among Ugandan female sex workers. Qual Health Res. 2021;31(3):443–57.PubMedPubMedCentral

65.

Shrestha R, Alias H, Wong LP, Altice FL, Lim SH. Using individual stated-preferences to optimize HIV self-testing service delivery among men who have sex with men (MSM) in Malaysia: results from a conjoint-based analysis. BMC Public Health. 2020;20(1):1–11.

66.

Dourado I, Magno L, Soares F, Massa P, Nunn A, Dalal S, et al. Adapting to the COVID-19 pandemic: continuing HIV prevention services for adolescents through telemonitoring, Brazil. AIDS Behav. 2020;24:1994–9.PubMed

67.

Louw J, Rantloane B, Ngcobo S, Brey Z, Hugo J, Basu D, et al. Home delivery of medication as part of reducing congestion in primary healthcare in Tshwane District Health Services. South Afr J Public Health (incorporating Strengthening Health Systems). 2020;4(2):50–5.

68.

Girometti N, McCormack S, Devitt E, Gedela K, Nwokolo N, Patel S, et al. Evolution of a pre-exposure prophylaxis (PrEP) service in a community-located sexual health clinic: concise report of the PrEPxpress. Sex health. 2018;15(6):598–600.PubMed

Titel: Novel Platforms for Biomedical HIV Prevention Delivery to Key Populations — Community Mobile Clinics, Peer-Supported, Pharmacy-Led PrEP Delivery, and the Use of Telemedicine
verfasst von: E. Rousseau
R. F. Julies
N. Madubela
S. Kassim
Publikationsdatum: 27.10.2021
Verlag: Springer US
Erschienen in: Current HIV/AIDS Reports / Ausgabe 6/2021
Print ISSN: 1548-3568
Elektronische ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-021-00578-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2021

Soluble Biomarkers of Cognition and Depression in Adults with HIV Infection in the Combination Therapy Era

Multi-level Interventions to Promote Oral Pre-exposure Prophylaxis Use Among Adolescent Girls and Young Women: a Review of Recent Research

HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups

Central Nervous System Effects of COVID-19 in People with HIV Infection

Correction to: Interventions Addressing Depression and HIV-Related Outcomes in People with HIV